|4Jan 3, 8:39 PM ET

Arumugham Rasappa 4

4 · Ocugen, Inc. · Filed Jan 3, 2020

Insider Transaction Report

Form 4
Period: 2020-01-02
Arumugham Rasappa
Chief Scientific Officer
Transactions
  • Award

    Options (Right to Buy)

    2020-01-02+111,372111,372 total
    Exercise: $0.51Exp: 2030-01-02Common Stock (111,372 underlying)
Footnotes (1)
  • [F1]The options will vest annually in equal installments over three years commencing on January 2, 2021, subject to continued employment with the Company on the applicable vesting dates.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT